Gynecology blend | Bacterial vaginosis
- Lactobacillus fermentum – LF15 (DSM 26955)
- Lactobacillus plantarum – LP01 (LMG P-21021)
DAILY DOSAGE IN CLINICAL STUDY
400 million CFU/strain/tablet + Tara gum + FOS + Arabinogalactan
Vaginal health • Inhibition of Gardnerella vaginalis • Counteraction of Bacterial Vaginosis (BV)
Human clinical trial
Vicariotto F. et al. Effectiveness of the two microorganisms L. fermentum LF15 and L. plantarum LP01, formulated in slow release vaginal tablets, in women affected by Bacterial Vaginosis: a pilot study. J Clin Gastroenterol. 2014; 48 Suppl:S106-112.